Silicon Labs Reports Third Quarter 2024 Results
[ Back ]   [ More News ]   [ Home ]
Silicon Labs Reports Third Quarter 2024 Results

AUSTIN, Texas, Nov. 4, 2024 — (PRNewswire) —  Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the third quarter, which ended September 28, 2024.

"Silicon Labs delivered solid sequential revenue growth as several key design wins began ramping in the quarter," said Matt Johnson, President and Chief Executive Officer at Silicon Labs. "Looking ahead, progress on inventory destocking and demand recovery remains uneven across our end markets. Despite the uncertain market backdrop in the near-term, we remain well-positioned for long-term growth and market share expansion."

Third Quarter Financial Highlights 

Results on a GAAP basis:

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

Business Highlights

Business Outlook

The company expects fourth-quarter revenue to be between $161 to $171 million. The company also estimates the following results:

On a GAAP basis:

On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:

Earnings Webcast and Conference Call 

Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 3:30 pm CDT today. An audio webcast will be available on Silicon Labs' website ( www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at investor.silabs.com and make a replay available through December 4, 2024.

About Silicon Labs 

Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of COVID-19 on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders. 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations 

(In thousands, except per share data) 

(Unaudited)



Three Months Ended


Nine Months Ended


September 28,
2024


September 30,
2023


September 28,
2024


September 30,
2023

Revenues

$           166,395


$           203,760


$           418,137


$           695,413

Cost of revenues

76,082


84,735


196,172


278,753

Gross profit

90,313


119,025


221,965


416,660

Operating expenses:








Research and development

83,228


79,042


249,787


254,340

Selling, general and administrative

36,793


27,766


109,041


113,363

Operating expenses

120,021


106,808


358,828


367,703

Operating income (loss)

(29,708)


12,217


(136,863)


48,957

Other income (expense):








Interest income and other, net

3,487


2,938


9,009


15,554

Interest expense

(278)


(1,359)


(1,050)


(4,611)

Income (loss) before income taxes

(26,499)


13,796


(128,904)


59,900

Provision for income taxes

2,005


3,388


38,283


23,479

Equity-method loss


(60)



(1,150)

Net income (loss)

$            (28,504)


$             10,348


$         (167,187)


$             35,271









Earnings (loss) per share:








Basic

$                (0.88)


$                  0.33


$                (5.21)


$                  1.11

Diluted

$                (0.88)


$                  0.32


$                (5.21)


$                  1.07









Weighted-average common shares outstanding:








Basic

32,309


31,796


32,114


31,789

Diluted

32,309


32,078


32,114


32,919

 

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)




Three Months Ended

September 28, 2024

Non-GAAP Income Statement Items


GAAP

Measure


GAAP

Percent of

Revenue


Stock

Compensation

Expense


Intangible Asset

Amortization


Non-GAAP

Measure


Non-GAAP

Percent of

Revenue

Revenues


$    166,395
























Gross profit


90,313


54.3 %


$                369


$                —


$         90,682


54.5 %














Research and development


83,228


50.0 %


10,255


5,438


67,535


40.6 %














Selling, general and administrative


36,793


22.1 %


5,279



31,514


18.9 %














Operating expenses


120,021


72.1 %


15,534


5,438


99,049


59.5 %














Operating income (loss)


(29,708)


(17.9 %)


15,903


5,438


(8,367)


(5.0 %)

 



Three Months Ended

September 28, 2024

Non-GAAP Loss Per Share


GAAP

Measure


Stock

Compensation

Expense*


Intangible

Asset

Amortization*


Income

Tax

Adjustments


Non-

GAAP

Measure

Net income (loss)


$    (28,504)


$          15,903


$             5,438


$             3,036


$        (4,127)












Diluted shares outstanding


32,309








32,309












Diluted loss per share


$        (0.88)








$          (0.13)


*   Represents pre-tax amounts

 

Unaudited Forward-Looking Statements Regarding Business Outlook

(In millions, except per share data)




Three Months Ended
December 28, 2024

Business Outlook


GAAP

Measure


Non-GAAP

Adjustments**


Non-GAAP

Measure

Gross margin


54% to 55%


— %


54% to 55%








Operating expenses


$118 to $122


$(21) to $(23)


$97 to $99








Diluted loss per share


$(0.75) to $(1.05)


$0.74 to $0.84


$(0.01) to $(0.21)


**  Non-GAAP adjustments include the following estimates: stock compensation expense of $16.8 million, intangible asset amortization of $5.4 million, and the application of a long-term non-GAAP tax rate of 20%.

 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets 

(In thousands, except per share data) 

(Unaudited)



September 28,
2024


December 30,
2023

Assets




Current assets:




   Cash and cash equivalents

$           303,082


$           227,504

   Short-term investments

66,596


211,720

   Accounts receivable, net

48,879


29,295

   Inventories

139,489


194,295

   Prepaid expenses and other current assets

56,090


75,117

Total current assets

614,136


737,931

Property and equipment, net

135,317


145,890

Goodwill

376,389


376,389

Other intangible assets, net

41,936


59,533

Other assets, net

81,464


123,313

Total assets

$        1,249,242


$        1,443,056

Liabilities and Stockholders' Equity




Current liabilities:




   Accounts payable

$             44,648


$             57,498

   Revolving line of credit


45,000

   Deferred revenue and returns liability

8,478


2,117

   Other current liabilities

65,179


58,955

Total current liabilities

118,305


163,570

Other non-current liabilities

49,551


70,804

Total liabilities

167,856


234,374

Commitments and contingencies




Stockholders' equity:




   Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued


   Common stock – $0.0001 par value; 250,000 shares authorized; 32,343 and 31,897
   shares issued and outstanding at September 28, 2024 and December 30, 2023,
   respectively

3


3

   Additional paid-in capital

55,567


16,973

   Retained earnings

1,025,544


1,192,731

   Accumulated other comprehensive income (loss)

272


(1,025)

Total stockholders' equity

1,081,386


1,208,682

Total liabilities and stockholders' equity

$        1,249,242


$        1,443,056

 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows 

(In thousands) 

(Unaudited)



Nine Months Ended


September 28,
2024


September 30,
2023

Operating Activities




Net income (loss)

$         (167,187)


$             35,271

Adjustments to reconcile net income to net cash used in operating activities:




Depreciation of property and equipment

19,302


18,992

Amortization of other intangible assets

17,596


19,162

Amortization of debt issuance costs


960

Stock-based compensation expense

45,358


37,167

Equity-method loss


1,150

Deferred income taxes

29,100


(5,881)

Changes in operating assets and liabilities:




Accounts receivable

(19,585)


(30,706)

Inventories

54,724


(66,971)

Prepaid expenses and other assets

23,091


8,085

Accounts payable

(13,849)


(37,039)

Other current liabilities and income taxes

(5,004)


(39,155)

Deferred revenue and returns liability

6,361


3,286

Other non-current liabilities

(13,946)


6,794

Net cash used in operating activities

(24,039)


(48,885)





Investing Activities




Purchases of marketable securities

(28,363)


(91,493)

Sales of marketable securities

44,057


365,073

Maturities of marketable securities

131,008


171,766

Purchases of property and equipment

(7,785)


(18,533)

Proceeds from sale of equity investment

12,382


Purchases of other assets


(395)

Net cash provided by investing activities

151,299


426,418





Financing Activities




Proceeds from revolving line of credit


80,000

Payments on debt

(45,000)


(571,157)

Repurchases of common stock


(217,137)

Payment of taxes withheld for vested stock awards

(16,078)


(17,239)

Proceeds from the issuance of common stock

9,396


8,013

Net cash used in financing activities

(51,682)


(717,520)





Increase (decrease) in cash and cash equivalents

75,578


(339,987)

Cash and cash equivalents at beginning of period

227,504


499,915

Cash and cash equivalents at end of period

$           303,082


$           159,928

 

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/silicon-labs-reports-third-quarter-2024-results-302295817.html

SOURCE Silicon Labs

Contact:
Company Name: Silicon Labs
Thomas Haws, Investor Relations Manager, (512) 416-8500
Email Contact
Financial data for Silicon Labs